Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2018-09-23 Tx date 2018-09-19 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-302,947.50
-46,500 vol $6.51 each |
204,352 | |
Filed 2018-08-24 Tx date 2018-08-23 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-181,800
-40,400 vol $4.50 each |
250,852 | |
Filed 2018-06-26 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-218,800
-40,000 vol $5.47 each |
291,252 | |
Filed 2017-12-11 Tx date 2017-12-06 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$616,439
+311,333 vol $1.98 each |
444,633 | |
Filed 2017-12-11 Tx date 2017-12-06 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$308,220
+155,667 vol $1.98 each |
600,300 | |
Filed 2017-12-04 Tx date 2017-11-30 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-104,098.50
-55,000 vol $1.89 each |
331,252 | |
Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-12 Tx date 2017-06-01 |
$ACST
Acasti Pharma Inc. |
Brouillette, François-Karl
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-06-12 Tx date 2017-06-01 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
133,300 | ||
Filed 2017-06-12 Tx date 2017-06-01 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Brouillette, François-Karl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
386,252 |